You are required to be logged in to access the full website
Click here if you have forgotten your username or password
14 February 2025 - Australian biotechnology company CSL Limited (ASX:CSL) (USOTC:CSLLY) and US-based mRNA medicines and vaccines company Arcturus Therapeutics (Nasdaq: ARCT) announced on Friday that the the European Commission has granted marketing a...
14 February 2025 - Dermatology specialist Galderma (SWX:GALD) announced on Friday that it has received European Commission approval for Nemluvio to treat moderate-to-severe atopic dermatitis in patients aged 12 years and older and moderate-to-severe ...
14 February 2025 - AroCell AB (Nasdaq First North Growth Market:AROC), a Swedish supplier of blood and urine sample tests, announced on Friday that it has received patent approval in China for its invention on detecting and classifying respiratory in...
14 February 2025 - Australian biotechnology company CSL (ASX:CSL; USOTC:CSLLY) announced on Thursday that it has received approval from the European Commission for ANDEMBRY (garadacimab), the first and only once-monthly treatment targeting factor XII...
14 February 2025 - Research-led pharmaceutical company Glenmark Pharmaceuticals Inc USA announced on Thursday that it has introduced Clindamycin Phosphate Foam, 1% in the United States.The product is bioequivalent and therapeutically equivalent to th...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe